Multicenter phase II study of the CyclOBEAP (CHOP-like + etoposide and bleomycin) regimen for patients with poor-prognosis aggressive lymphoma
- Nozomi Niitsu
- , Masataka Okamoto
- , Sadao Aoki
- , Hirokazu Okumura
- , Tadashi Yoshino
- , Ikuo Miura
- , Masami Hirano
研究成果: ジャーナルへの寄稿 › 学術論文 › 査読
20
被引用数
(Scopus)